Page last updated: 2024-09-03

rc 3095 and Ache

rc 3095 has been researched along with Ache in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cancella, A; da Rocha, AB; De Nucci, G; DiLeone, LP; Horowitz, M; Pereira, AS; Pohlmann, P; Richter, M; Schunemann, D; Schwartsmann, G; Souza, F; Souza, FH1

Trials

1 trial(s) available for rc 3095 and Ache

ArticleYear
A phase I trial of the bombesin/gastrin-releasing peptide (BN/GRP) antagonist RC3095 in patients with advanced solid malignancies.
    Investigational new drugs, 2006, Volume: 24, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Bombesin; Female; Gastrin-Releasing Peptide; Gastrins; Humans; Injections, Subcutaneous; Male; Middle Aged; Neoplasms; Pain; Peptide Fragments; Skin

2006